From Abstract to Action: Translating ASCO26 Research Into Global Practice
ASCO Daily News
How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India’s health care landscape as a blueprint for resource-limited settings.
info_outline
Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough
ASCO Daily News
Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region.
info_outline
Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1
ASCO Daily News
Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting.
info_outline
GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART
ASCO Daily News
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASCO Annual Meeting.
info_outline
Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
ASCO Daily News
Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting.
info_outline
GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
ASCO Daily News
Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting.
info_outline
Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More
ASCO Daily News
Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders.
info_outline
Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More
ASCO Daily News
Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC.
info_outline
Day 5: Top Takeaways From ASCO26
ASCO Daily News
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.
info_outline
Day 4: Top Takeaways From ASCO26
ASCO Daily News
Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma.
info_outlineDr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.